Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis
NCT06609343Phase 2Not yet recruiting
- Sponsor
- UT Health San Antonio
- Start
- Feb 2027
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupropion in fatigue, sponsored by UT Health San Antonio. Planned start Feb 2027; status: not yet recruiting.
02
Drugs
bupropion
03
Conditions
fatigue
Beyond the preview
Go deeper on NCT06609343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06609343.